| Report ID |
125088 |
| Drug Identification Number |
02377225 |
| Brand name |
MOZOBIL |
| Common or Proper name |
Mozobil |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
PLERIXAFOR |
| Strength(s) |
20MG |
| Dosage form(s) |
SOLUTION |
| Route of administration |
SUBCUTANEOUS
SUBCUTANEOUS |
| Packaging size |
1 x 2.0ml |
| ATC code |
L03AX |
| ATC description |
IMMUNOSTIMULANTS |
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
2020-12-04 |
| Actual start date |
|
| Estimated end date |
Unknown |
| Actual end date |
2020-11-25 |
| Shortage status |
Avoided shortage |
| Updated date |
2020-11-25 |
| Company comments |
production/ supply delay - Considering the exceptional circumstances, the remaining stock will be distributed on allocation with a limit of 2 vials per order. Pharmacies are invited to communicate with their preferred distributor to obtain more information on product availability. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
